Immune Responses to Gluten (NCT05209568)

🧪 Interventions in This Study

• Gluten Powder (DIETARY_SUPPLEMENT)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (2 Sites)

• Children's Hospital Colorado — Aurora, Colorado
• Boston Children's Hospital — Boston, Massachusetts

📞 Contact the Study Coordinator

Phone: (617) 355-8880

Email: jocelyn.silvester@childrens.harvard.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Celiac Disease

• A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease — Murrieta, California
• A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease — Stanford, California
• Tissue Destruction and Healing in Celiac Disease — Pasadena, California
• Gluten Technology and Education for Celiac Health — Chicago, Illinois
• Study of DONQ52 in Active Celiac Disease — Anniston, Alabama

Explore by condition: All Celiac Disease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.